← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2017Last known activity
Jun 30, 2020
Acquired by UCB on Oct 10, 2019
Timeline
2000s
- Jun 1, 2008
Ra Pharmaceuticals— Founded
2010s
- Oct 10, 2019
UCB— Acquired By
Drugs by trial phase (1 distinct, 8 trials)
Phase 3 (1 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT04436497CollaboratorPhase 2/Phase 3Jun 30, 2020
- NCT04225871Lead sponsorPhase 3Jan 31, 2020
- NCT04025632Lead sponsorPhase 2Nov 30, 2019
- NCT04115293Lead sponsorPhase 3Oct 1, 2019
- NCT03315130Lead sponsorPhase 2Oct 11, 2017
- NCT03225287Lead sponsorPhase 2Jul 17, 2017
- NCT03078582Lead sponsorPhase 2Mar 1, 2017
- NCT03030183Lead sponsorPhase 2Feb 1, 2017
Details
- Founded
- Cambridge, MA, US Jun 1, 2008
- Last known activity
- Jun 30, 2020